Cerus Corp (CERS) stock saw a modest uptick, ending the day at $1.8 which represents a slight increase of $0.02 or 1.12% from the prior close of $1.78. The stock opened at $1.81 and touched a low of ...
(RTTNews) - Celldex Therapeutics, Inc. (CLDX), Wednesday announced results from phase 2 study of barzolvolimab for treatment of chronic spontaneous urticaria, an immune-related condition. At the end ...